Month: March 2025

Sword Bio (“Sword”), a contract research organization that supports biotech and pharmaceutical companies with their bioanalytical needs for pre-clinical and clinical trials, announces the appointment of Jim McNally as Chief Scientific Officer. Dr. McNally joins Sword with an extensive background in bioanalytical assay development and biotherapeutic program leadership spanning more than 25 years working in…